High income (World Bank) vs Oman: Measles-containing-vaccine second-dose (MCV2) immunization coverage
High income (World Bank)
91.0%
in 2025
Oman
99.0%
in 2025
High income (World Bank) rank
2nd
Oman rank
1st
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- High income (World Bank)
- Oman
How they compare
Oman currently reports 99.0% against 91.0% in High income (World Bank), a difference of 8.0%.
That makes Oman's figure about 1.1 times High income (World Bank)'s.
Across all 26 years both countries report, Oman has been ahead every year.
High income (World Bank) ranks 2nd and Oman ranks 1st of 11 groups.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | High income (World Bank) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.6% | 97.8% | 32.2% | Oman |
| 2010s | 89.4% | 98.9% | 9.5% | Oman |
| 2020s | 91.5% | 98.8% | 7.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, High income (World Bank) or Oman?
- Oman, at 99.0% against 91.0% in High income (World Bank) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between High income (World Bank) and Oman?
- 8.0%, with Oman ahead.
- How many years of comparable data are there for High income (World Bank) and Oman?
- 26 years are reported by both, from 2000 to 2025.
- How do High income (World Bank) and Oman rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- High income (World Bank) ranks 2nd and Oman ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.